At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551. doi: 10.1164/rccm.201710-2028PP.

Authors

Fernando J Martinez^{1

2}, MeiLan K Han², James P Allinson³, R Graham Barr⁴, Richard C Boucher⁵, Peter M A Calverley⁶, Bartolome R Celli⁷, Stephanie A Christenson⁸, Ronald G Crystal¹, Malin Fagerås⁹, Christine M Freeman^{2

10}, Lars Groenke¹¹, Eric A Hoffman¹², Mehmet Kesimer⁵, Kostantinos Kostikas¹³, Robert Paine 3rd^{14

15}, Shahin Rafii¹, Stephen I Rennard¹¹, Leopoldo N Segal¹⁶, Renat Shaykhiev¹, Christopher Stevenson¹⁷, Ruth Tal-Singer¹⁸, Jørgen Vestbo¹⁹, Prescott G Woodruff⁸, Jeffrey L Curtis^{2

10}, Jadwiga A Wedzicha³

Affiliations

¹ 1 Weill Cornell Medical College, New York, New York.
² 2 University of Michigan School of Medicine, Ann Arbor, Michigan.
³ 3 Imperial College, London, United Kingdom.
⁴ 4 Columbia University, New York, New York.
⁵ 5 University of North Carolina, Chapel Hill, North Carolina.
⁶ 6 School of Clinical Sciences, Liverpool, United Kingdom.
⁷ 7 Harvard School of Medicine, Boston, Massachusetts.
⁸ 8 University of California at San Francisco, San Francisco, California.
⁹ 9 AstraZeneca Corporation, London, United Kingdom.
¹⁰ 10 Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
¹¹ 11 Boehringer Ingelheim, Ingelheim, Germany.
¹² 12 University of Iowa Carver College of Medicine, Iowa City, Iowa.
¹³ 13 Novartis Pharma, Basel, Switzerland.
¹⁴ 14 University of Utah, Salt Lake City, Utah.
¹⁵ 15 Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah.
¹⁶ 16 New York University, New York, New York.
¹⁷ 17 Janssen Pharmaceutica, Beerse, Belgium.
¹⁸ 18 GlaxoSmithKline, King of Prussia, Pennsylvania; and.
¹⁹ 19 Odense University Hospital, Odense, Denmark.

No abstract available

Publication types

Comparative Study

MeSH terms

Adult
Age of Onset*
Aged
Aged, 80 and over
Disease Progression*
Early Diagnosis*
Female
Humans
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive / classification*
Pulmonary Disease, Chronic Obstructive / diagnosis
Pulmonary Disease, Chronic Obstructive / physiopathology
Pulmonary Disease, Chronic Obstructive / therapy*

Grants and funding